Neuraxis appoints timothy henrichs as chief financial officer

Carmel, ind., jan. 31, 2024 (globe newswire) -- neuraxis, inc. (nyse american: nrxs) (“neuraxis” or the “company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced the appointment of timothy henrichs as chief financial officer (cfo), effective february 5, 2024. as part of his appointment, mr. henrichs has resigned as an independent director on the board of neuraxis (the “board”).
NRXS Ratings Summary
NRXS Quant Ranking